Societal preferences for adjuvant melanoma health states: UK and Australia

Abstract Background No studies have measured preference-based utility weights for specific toxicities and outcomes associated with approved and investigational adjuvant treatments for patients with resected high-risk melanoma. Methods A cross-sectional study was conducted in the United Kingdom and A...

Full description

Bibliographic Details
Main Authors: Mark R. Middleton, Michael B. Atkins, Kaitlan Amos, Peter Feng Wang, Srividya Kotapati, Javier Sabater, Kathleen Beusterien
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Cancer
Online Access:http://link.springer.com/article/10.1186/s12885-017-3673-y